The Squeeze: Highlights from RSNA 2024
Living up to its potential, AI stole the spotlight at RSNA 2024. The message from clinicians was clear—the time to implement AI is now.
But with a surge of new AI players in radiology, many untested and lacking clinical validation, choosing the right AI partner has never been more critical.
Volpara and Lunit have been listening. We understand that delivering on AI's promise is more than just implementing a new tool; it’s about a fully integrated ecosystem that seamlessly connects data, workflows, and clinical insights.
Keep reading to learn more about how our proven solutions and ecosystem approach make us the ideal partner for advancing your breast imaging program.
Let's go! Becky Weber, EVP, Sales
3 Things to Know this Month
[Watch] Radiologists from UC Davis and Mosaic Breast Imaging discuss mammography AI adoption. Choosing the right AI tools for your busy practice can feel overwhelming. Gain firsthand insights about the benefits, including reduced errors, fewer unnecessary recalls and biopsies, and earlier cancer detection from two practicing radiologists. Curious about how AI can elevate your practice? Get the inside scoop in this Imaging Wire interview.
Why one CEO is excited about breast imaging AI. As healthcare evolves, one thing is clear—AI is poised to revolutionize breast imaging, and Volpara and Lunit are at the forefront. Teri Thomas, CEO of Volpara Health and Chief Business Officer of Lunit, shared her excitement about the future of AI in radiology with MedCity News. She highlights how the groundbreaking collaboration between the two organizations is advancing the integration of cutting-edge AI tools into mammography by enhancing image analysis, improving patient care, and supporting clinical teams with greater efficiency and accuracy. Discover how the power of our partnership is shaping the future of breast imaging.
Setting a new standard: Introducing a growing ecosystem for early detection. At RSNA, Lunit and Volpara Health unveiled an exciting vision for the future of AI in healthcare—a powerful ecosystem that unites our strengths in breast cancer detection, mammography, and chest X-rays. Leveraging over 130 million medical images and clinical data points, together, we're creating an integrated, end-to-end solution that promises to streamline workflows, improve patient care, and set a new standard for AI in healthcare. Read the interview now.
When it comes to better risk assessment, more IS more
The future of risk assessment is compelling and success lies in using the right combination of tools.
For years, breast centers have informally assessed risk or relied on limited, ‘easy button’ tools to identify patient risk. Restrictive tools or failing to adopt a cohesive strategy may lead to significant gaps. Discover the current state of comprehensive risk assessment and explore where the future is headed.
Data snapshot: Standalone AI improves specificity, reduces false positives
A recent Lunit INSIGHT DBT study published in Radiology shows standalone AI demonstrated significantly higher specificity than radiologist interpretation of breast exams, reducing false positives and unnecessary recalls.
When used adjunctively with radiologists, INSIGHT DBT improved sensitivity and specificity while cutting reading times by up to 15% reduction per case. This study highlights AI's potential to enhance efficiency and accuracy in diagnosing breast cancer, particularly in cases with soft tissue lesions. Learn more about these findings in the full study.
Upcoming Events
NCoBC2025: The 34th Annual National Consortium of Breast Centers Conference
March 21-23 | Las Vegas, NV
Join your peers at Caesar’s Las Vegas, March 21-23 for the 34th Annual National Consortium of Breast Centers Conference (NCBC). Don’t miss out on this unique learning opportunity for your team to come together, explore innovative approaches, and earn valuable CE credits.
Before you go…
AdventHealth is reshaping breast cancer risk assessment with its innovative Genomics Risk Assessment for Cancer and Early Detection (GRACE) program.
Fueled by Volpara's advanced algorithms that deliver personalized risk profiles for patients, GRACE will serve 100,000 patients annually. AdventHealth is setting a new standard for early detection and prevention. Discover how GRACE is transforming care.